CC[C@@]1(O)C[C@H](OC2CC(N(C)C)C(O)C(C)O2)c2c(O)c3c(c(O)c2[C@H]1OC1CC(N(C)C)C(O)C(C)O1)C(=O)c1cccc(O)c1C3=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?